Loading…
CRON
Cronos Group Inc.
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic
$3.38-0.29%
Key metrics
- Market cap
- $1.25B
- P/E
- 17.8x
- Forward P/E
- —
- P/B
- 1.2x
- Dividend yield
- —
- EPS
- $0.19
- ROE
- 7.05%
- Profit margin
- 39.08%
- Revenue growth
- +58.40%
- Beta
- 1.24
- 52-week high
- $3.61
- 52-week low
- $2.28
History
How the company evolved, year by year. Revenue and debt come from the annual statements; dividends from the payments themselves, which reach further back.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
About the company
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
- 610
- Stayner, Canada
Company description provided by Yahoo Finance.